Lexatumumab, the monoclonal antibody, presents significant promise in the treatment against cancer disease. This new agent selectively binds to lthe HER3 molecule, that is commonly overexpressed in various tumoral https://mediajx.com/story28045787/lexatumumab-a-hopeful-treatment-for-tumors